BioCryst Pharmaceuticals BCRX Inventory turnover
Inventory turnover at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's inventory turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's inventory turnover?
- BioCryst Pharmaceuticals (BCRX) reported inventory turnover of 0.7× in Q1 2026.
- How has BioCryst Pharmaceuticals's inventory turnover changed year-over-year?
- BioCryst Pharmaceuticals's inventory turnover increased by 35.4% year-over-year, from 0.6× to 0.7×.
- What is the long-term trend for BioCryst Pharmaceuticals's inventory turnover?
- Over 2 years (2021 to 2025), BioCryst Pharmaceuticals's inventory turnover has grown at a 13.0% compound annual growth rate (CAGR), from 0.6× to 0.8×.
- What does inventory turnover mean?
- Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.